Welcome to our dedicated page for 1933 Inds news (Ticker: TGIFF), a resource for investors and traders seeking the latest updates and insights on 1933 Inds stock.
News and updates for 1933 Industries Inc. (CSE:TGIF, OTC:TGIFF) focus on its role as a Nevada-based licensed wholesale producer of cannabis consumer products. The company’s releases highlight its cultivation and extraction activities at a 68,000 sq. ft. indoor facility and the performance of its flagship brands, particularly Alternative Medicine Association (AMA) and Level X, in the Nevada market.
Readers can expect news about financial results, where 1933 Industries reports on revenue, gross profit, margins and net income, along with commentary on operational efficiencies and cost-saving initiatives. The company has emphasized periods of positive income, consecutive profitable quarters and improvements in earnings, positioning these updates within the context of the Nevada cannabis market and broader industry conditions.
Another key news theme is the company’s capital structure and convertible debentures. Releases describe the issuance, repurchase and cancellation of unsecured convertible debentures, as well as reminders and guidance to debenture holders regarding conversion deadlines and terms. The company explains how debenture conversions and repurchases affect its outstanding liabilities, liquidity and ability to continue operating, and why conversion is viewed by the board as a constructive outcome for stakeholders.
News items also address regulatory and industry developments, including references to U.S. federal actions related to cannabis scheduling and amendments to the Farm Bill affecting hemp-derived products. 1933 Industries discusses how these changes may influence competition from hemp-derived THC products and create potential opportunities for licensed operators in legal states such as Nevada. For ongoing insight into the company’s operations, financial performance, balance sheet actions and regulatory commentary, this news feed provides a consolidated view of 1933 Industries’ public communications.
1933 Industries (OTC PINK:TGIFF) reported its Q2 2025 financial results, showing revenue of $4.4 million, an 11% increase from Q1 2025. The company achieved a gross profit of $1.5 million with a 35% gross margin, up from 30% in Q2 2024. The net loss narrowed to $0.3 million, improving from $0.6 million in Q2 2024.
The company's Alternative Medicine Association (AMA) maintained its second place ranking in Nevada's flower category. Total revenues for Fiscal 2025 reached $8.4 million, down from $9.8 million in Fiscal 2024, attributed to slower Q1 2025 retail sales. Operating expenses decreased to $1.8 million from $2.0 million year-over-year, primarily due to reduced wages and benefits.
1933 Industries (OTC:TGIFF) reported its Q1 2025 financial results, showing mixed performance amid challenging market conditions in Nevada. The company generated revenue of $4.0 million, down from $5.2 million in Q1 2024, with the decline attributed to soft sales and falling flower prices across Nevada.
Key financial metrics include a gross profit of $1.3 million (vs $1.6 million in Q1 2024), improved gross margin of 33% (vs 31% in Q1 2024), and a net loss of $0.58 million (compared to $0.38 million loss in Q1 2024). Operating expenses decreased to $1.9 million from $2.0 million year-over-year.
The company's Alternative Medicine Association (AMA) brand achieved a notable #3 ranking among Nevada's most sold cannabis brands by volume, demonstrating resilience despite market price compression. Nevada's retail cannabis sales showed significant decline, falling 23% from $78 million in August to $59.8 million in September 2024.
1933 Industries reported record revenues of $19.3 million for fiscal year 2024, marking a 15% increase year-over-year. The company significantly improved its financial performance with:
- Gross profit of $2.9 million, compared to a loss of $1.4 million in 2023
- Increased gross margin by 14%
- Reduced net loss to $0.6 million from $14.6 million in 2023
The Nevada-focused cannabis cultivator, through its 91%-owned subsidiary Alternative Medicine Association (AMA), has established itself as a top-selling cannabis brand in Nevada. The company's improved performance stems from operational efficiency, optimized cultivation, and fair market valuation of biological assets. During the period, the company discontinued its Canna Hemp CBD subsidiary due to declining market conditions.
1933 Industries (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, has announced key leadership changes effective February 1st, 2025. Jeremy Fong, a Certified Public Accountant with extensive experience in public company financial reporting and compliance, has been appointed as Chief Financial Officer. His background includes executing corporate operational audits and financial statement disclosure for NASDAQ-listed and Fortune 1000 companies.
The current CFO, Brian Farrell, will transition to the roles of Interim Chief Executive Officer and Interim Chairman of the Board. Additionally, Kathy Estochin, who has led the company's Finance Department since 2020, has been promoted to VP Finance and Administration, bringing over 35 years of accounting experience across various industries.
1933 Industries (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis company, announced it will not meet the January 27, 2025 deadline for filing its audited financial statements for the year ended July 31, 2024, and expects to receive a Cease Trade Order. The company had previously obtained a Management Cease Trade Order (MCTO) on November 29, 2024, restricting trading by key executives including CEO Paul Rosen, CFO Brian Farrell, and Director Curtis Floyd.
The company anticipates completing the required Audited Filings in February 2025, after which the Cease Trade Order should be lifted. Additionally, the Q1 2025 financial report for the period ended October 31, 2024, will be delayed until after the completion of the Audited Filings. The company confirms no material changes or insolvency proceedings since their previous announcement.
1933 Industries (CSE:TGIF)(PINK:TGIFF) provided an update regarding its delayed filing of audited financial statements for the year ended July 31, 2024. The British Columbia Securities Commission granted a management cease trade order (MCTO) on November 29, 2024, restricting trading by key executives until the filings are complete, expected by January 27, 2025.
The company also announced that CEO Paul Rosen will step down effective February 1st, 2025, though remaining on the Board of Directors. Current CFO Brian Farrell, who has served on the Board since 2018, will assume the role of Interim CEO. Under Rosen's leadership since 2020, the company achieved profitability for the first time by restructuring debt, reducing workforce, and enhancing management. The company's 'AMA' brand is now among Nevada's top-selling cannabis brands.
The Q1 2025 financial report will be delayed until after the completion of the Audited Filings.
1933 Industries (CSE:TGIF)(OTC PINK:TGIFF) provided an update regarding its delayed filing of audited financial statements for the year ended July 31, 2024. The British Columbia Securities Commission granted a Management Cease Trade Order (MCTO) on November 29, 2024, restricting trading by key executives until the filings are complete. The company expects to finalize the Audited Filings by January 27, 2025.
During this period, shareholders can continue trading, but an insider trading blackout has been imposed. The Q1 2025 financial report for the period ended October 31, 2024, will be delayed until after the completion of the Audited Filings. The company confirmed no material changes or defaults since the initial announcement and is not subject to insolvency proceedings.
1933 Industries (CSE:TGIF)(OTC PINK:TGIFF) provides an update regarding its management cease trade order (MCTO) for delayed filing of audited financial statements for the year ended July 31, 2024. The British Columbia Securities Commission granted the MCTO on November 29, 2024, restricting trading by key executives until the filings are completed. The company expects to finalize the Audited Filings by January 27, 2025.
The Q1 2025 financial report will be delayed until after the Audited Filings are submitted. Additionally, the company's Alternative Medicine Association (AMA) brand has received a LeafLink List 2024 award for Top Selling in Nevada, based on performance data from January to September.